Literature DB >> 16535964

Outcome of infrainguinal revascularization for critical limb ischemia in diabetics with end stage renal disease.

F Sigala1, S Georgopoulos, S Langer, C Baunach, E Papalambros, K Sigalas, J Bramis, C Bakoyiannis, E Bastounis, W Hepp.   

Abstract

BACKGROUND: End stage renal disease [ESRD] and diabetes have a negative effect on outcome of arterial reconstructions, because they are associated with a vulnerability to infection, an infrageniculate arterial occlusive disease and an increased perioperative risk. The combination of both in critically ischemic patients is traditionally considered a great threat to their limb or life. The risk/benefit ratio of revascularization in this clinical setting is marginal and therefore the decision making is controversial. This study was undertaken to determine the results of arterial reconstruction in patients with end-stage renal disease and diabetes mellitus. PATIENTS AND METHODS: The outcome of 97 patients undergoing 121 arterial reconstructions due to lower limb threatening ischemia were reviewed. Primary and secondary patency rates as well as survival and limb salvage were estimated.
RESULTS: Thirty-day operative mortality rate was 10.3%. At one month, one year and 2 year follow-up, the survival rate was 89.7%, 77.6% and 44.2% respectively. Limb salvage at 6 months was 85.6%, at 12 months 75.3% and at 2 years 56.3%. The primary and secondary patency was 92.4% and 93.2% at 6 months and 71.7% and 72.7% at 12 months, respectively.
CONCLUSIONS: Diabeticpatients with ESRD attained an acceptable graft patency and limb salvage but they sustained higher perioperative mortality and morbidity and reduced survival.

Entities:  

Mesh:

Year:  2006        PMID: 16535964     DOI: 10.1024/0301-1526.35.1.15

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  5 in total

1.  The diabetic foot: a global threat and a huge challenge for Greece.

Authors:  N Papanas; E Maltezos
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

2.  [S3 guidelines for diagnostics and treatment of peripheral arterial occlusive disease].

Authors:  P Huppert; J Tacke; H Lawall
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

3.  Comprehensive approach to management of critical limb ischemia.

Authors:  Lanfroi Graziani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

Review 4.  Therapeutic angiogenesis in critical limb ischemia.

Authors:  Geoffrey O Ouma; Barak Zafrir; Emile R Mohler; Moshe Y Flugelman
Journal:  Angiology       Date:  2012-11-04       Impact factor: 3.619

5.  Recurrence of Critical Limb Ischemia After Endovascular Intervention in Patients with Diabetic Foot Ulcers.

Authors:  Marco Meloni; Valentina Izzo; Laura Giurato; Costantino Del Giudice; Valerio Da Ros; Valerio Cervelli; Roberto Gandini; Luigi Uccioli
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-06-01       Impact factor: 4.730

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.